Sino Biological announces services partnership with Rapid Novor

From Sino Biological Inc.Mar 21 2024Reviewed by Maria Osipova Sino Biological, Inc. , a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto, Canada-based Rapid Novor, Inc. .

Related StoriesHeadquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and related contract research services. A considerable portion of its custom contract research services is the design, development and manufacture of custom monoclonal antibodies for both basic research and in vitro diagnostics applications.

Rapid Novor’s REmAb monoclonal antibody sequencing capabilities perfectly complement Sino Biological’s antibody development and manufacturing services. We believe the combination of these services synergistically elevates the value of our custom monoclonal antibody products for our clients.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Haydale Graphene Inc.: Integrating Graphene into Commercial TechnologiesHaydale Graphene Inc. is a company that facilitates the integration of graphene and other nano-materials into the next generation of commercial technologies and industrial materials. With headquarters in Wales, UK and operational sites across the globe, the company was established in 2003 and has over 70 people and partners. Their unique patented process involves treating nano-material powders using plasma and gas chemistry.
Source: AZoNano - 🏆 106. / 51 Read more »